Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Eun Ju Cho, Su Jong Yu, So Young Kwon, Ji-Hoon Kim, Do Young Kim, Won Kim, June Sung Lee, Jin Woo Lee, Youn Jae Lee, Hee Bok Chae & Jung-Hwan Yoon. (2018) Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial. Drug Design, Development and Therapy 12, pages 3767-3774.
Read now
Read now
Articles from other publishers (19)
Jing Wu, Shitong Xie, Yanfang Ma, Xiaoning He, Xinyue Dong, Qianling Shi, Qiangqiang Guo, Qi Wang, Meixuan Li, Naijuan Yao & Liang Yao. (2023) Entecavir for children and adults with chronic hepatitis B. Cochrane Database of Systematic Reviews 2023:2.
Crossref
Crossref
Avery S. Ward, Chia-Heng Hsiung, Daniel G. Kesterson, Vasudeva G. Kamath & Edward E. McKee. (2022) Entecavir competitively inhibits deoxyguanosine and deoxyadenosine phosphorylation in isolated mitochondria and the perfused rat heart. Journal of Biological Chemistry 298:5, pages 101876.
Crossref
Crossref
Daiki Aomura, Naoki Tachibana, Michiharu Komatsu & Masakazu Kobayashi. (2020) Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B. Case Reports in Nephrology and Dialysis 10:3, pages 130-138.
Crossref
Crossref
Julien Marlet, Clément Lier, Emmanuelle Roch, Morgan Maugey, Alain Moreau, Benjamin Combe, Sandrine Lefeuvre, Louis d’Alteroche, Didier Barbereau, Xavier Causse, Frédéric Bastides, Marie-Nadege Bachelier, Denys Brand & Catherine Gaudy-Graffin. (2020) Revisiting HBV resistance to entecavir with a phenotypic approach. Antiviral Research 181, pages 104869.
Crossref
Crossref
Feng Zhou, Weidong Jia, Shuo Yang, Ge Chen, Guanhai Li, Yueping Li, Yingfang Liang, Yi Yang, Yanhui Gao & Yue Chen. (2018) Antiviral drug Utilization and Annual Expenditures for Patients with Chronic HBV Infection in Guangzhou, China, in 2008–2015. Antiviral Therapy 24:6, pages 405-416.
Crossref
Crossref
Aoran Luo, Xiaoyan Jiang & Hong Ren. (2018) Entecavir-based combination therapies for chronic hepatitis B. Medicine 97:51, pages e13596.
Crossref
Crossref
Mona H Ismail, Jane D Ricaforte-Campos, Charles S Wiysonge & Robert Gish. (2018) Entecavir versus other oral antiviral drugs for chronic hepatitis B. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Berthold Bivigou-Mboumba, Marie Amougou-Atsama, Samira Zoa-Assoumou, Hervé M’boyis Kamdem, Guy Francis Nzengui-Nzengui, Angélique Ndojyi-Mbiguino, Richard Njouom & Sandrine François-Souquière. (2018) Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence. PLOS ONE 13:1, pages e0190592.
Crossref
Crossref
Kehui Liu, Xiaogang Xiang, Rebecca Bao, Rong Chen, Yunye Liu, Jingdong Xie, Qing Guo, Shisan Bao, Qing Xie & Hui Wang. (2016) A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients. Scientific Reports 6:1.
Crossref
Crossref
Amal Chakkor, Fedoua Rouibaa, Safiaa Elaboudi & Aziz Aourarh. (2016) An evaluation of entecavir treatment among nucleos(t)ide-naïve Moroccan patients with chronic hepatitis B. BMJ Open Gastroenterology 3:1, pages e000081.
Crossref
Crossref
Joo Han Park, Seon Joo Ahn, Hyo Jung Cho, Soon Sun Kim, Jae Youn Cheong & Sung Won Cho. (2016) Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B. Journal of Medical Virology 88:2, pages 252-259.
Crossref
Crossref
Qian Qiu, Yan Li, Xiao-wan Duan, Li-kun Yang, Yu Chen, Hui Li, Li Wang & Zhong-ping Duan. (2014) Impact of a New Reimbursement Program on Hepatitis B Antiviral Medication Cost and Utilization in Beijing, China. PLoS ONE 9:10, pages e109652.
Crossref
Crossref
Tomoyuki Yamazaki, Tetsu Akimoto, Kousuke Okuda, Taro Sugase, Eri Takeshima, Akihiko Numata, Yoshiyuki Morishita, Yoshitaka Iwazu, Hiromichi Yoshizawa, Takanori Komada, Kana Iwazu, Osamu Saito, Fumi Takemoto, Shigeaki Muto & Eiji Kusano. (2014) Purpura with Ulcerative Skin Lesions and Mixed Cryoglobulinemia in a Quiescent Hepatitis B Virus Carrier. Internal Medicine 53:2, pages 115-119.
Crossref
Crossref
Dae Hun Kwon, In Hee Kim, Bum Su Choung, Dae Seon Ahn, Sun Ho Yoo, Sang Bae Park, Seok Lee, Seong Hun Kim, Sang Wook Kim & Yong Jin Im. (2013) Continuous Long-Term Entecavir Therapy in Naïve Chronic Hepatitis B Patients Showing Partial Virologic Response. Gut and Liver 7:6, pages 712-718.
Crossref
Crossref
Jian Liang, Man Jun Jiang, Xin Deng & Xiao Xiao Zhou. (2013) Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study. Hepatitis Monthly 13:5.
Crossref
Crossref
Ping-Wei Zhao, Fei-Yong Jia, Yu-Xing Shan, Hui-Fan Ji, Jun-Yan Feng, Jun-Qi Niu, Desalegn A Ayana & Yan-Fang Jiang. (2013) Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir. Clinical and Experimental Pharmacology and Physiology 40:3, pages 190-196.
Crossref
Crossref
MiAe Chu, Seung Man Cho, Byung-Ho Choe, Min Hyun Cho, Soonhak Kwon & Won Kee Lee. (2012) Virologic Responses to Add-on Adefovir Dipivoxil Treatment Versus Entecavir Monotherapy in Children With Lamivudine-resistant Chronic Hepatitis B. Journal of Pediatric Gastroenterology & Nutrition 55:6, pages 648-652.
Crossref
Crossref
Atsushi Ono, Fumitaka Suzuki, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitou, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki, Rie Mineta & Hiromitsu Kumada. (2012) Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients. Journal of Hepatology 57:3, pages 508-514.
Crossref
Crossref
Suk Jin HongByung-Ho Choe. (2012) Strategy to Overcome Drug Resistance That Develops during Treatment of Chronic Hepatitis B in Children. Pediatric Gastroenterology, Hepatology & Nutrition 15:2, pages 63.
Crossref
Crossref